BIOMIRA RESEARCH (BIOM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BIOMIRA RESEARCH (BIOM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: chirodoc who wrote (44)	1/30/2000 12:37:00 PM
From: chirodoc	Read Replies (1) of 72

One of the primary advantages of BIOM's liposomal formulation is the ability to contain a very toxic drug. Vaccines in general are not toxic though there are dangers. People have contracted polio from the Sabin vaccine meant to prevent it and vaccines can have severe allergic reactions. Liposomes also have the ability to dispense drugs over an extended period of time. LIPO was founded on the basis of liposomes and many companies have liposomal formulations. It appears that you need to evaluate liposomal IL-2 alone with any other research directions as speculative. Best, Terry

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next